Methamphetamine is a widely used stimulant drug that enhances release of the neurotransmitter dopamine in the human brain. The behavioral action of dopamine is mediated in part through stimulation of the enzyme adenylyl cyclase by way of the dopamine D
1 receptor. It has been suspected that some of the behavioral changes associated with chronic use of methamphetamine might be due to abnormal D
1 receptor function. Tong et al. (p.
896) report that postmortem D1 stimulation of adenylyl cyclase was 25%–30% lower in all three striatal subregions (nucleus accumbens, caudate, and putamen) of brains from long-term methamphetamine users than in comparison subjects without substance abuse or neuropathology. These data suggest that brain dopamine D
1 receptor function might be low in human methamphetamine users, a change that could explain some of the consequences (e.g., drug craving, tolerance) of repeated drug exposure.